AD128

DRUG2 trials

Sponsors

Raphael Heinzer, Istituto Auxologico Italiano

Conditions

Obstructive Sleep ApneaSleep Apnea, Obstructive

Phase 2

Effect of AD128 to Treat Obstructive Sleep Apnea

CompletedNCT04394143

Raphael HeinzerSleep Apnea, Obstructive

Start: 2020-10-20End: 2021-07-19Updated: 2021-08-06

Study of AD128 Versus Placebo in Obstructive Sleep Apnea

CompletedNCT04449133

Istituto Auxologico ItalianoObstructive Sleep Apnea

Start: 2020-07-03End: 2020-10-31Updated: 2021-09-27

Related Papers

Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial

SLEEP2023-03-028 citations

Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.

2021-09-2054 citations